A single nucleotide polymorphism of macrophage migration inhibitory factor is related to inflammatory response in coronary bypass surgery using cardiopulmonary bypass

European Journal of Cardio-thoracic Surgery

Volumn 30, Issue 1, 2006, Pages 59-63

  Lehmann, Lutz E ^a   Schroeder, Stefan ^b   Hartmann, Wolfgang ^a   Dewald, Oliver ^a   Book, Malte ^a   Weber, Stefan U ^a   Schewe, Jens Christian ^a   Stüber, Frank ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Klinik fur Anasthesie und Intensivmedizin   (Germany)

Author keywords

Cardiopulmonary bypass; Coronary artery bypass graft; MIF; Polymorphism; Promoter

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HEART MUSCLE REVASCULARIZATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYBRIDIZATION; INFLAMMATION; MAJOR CLINICAL STUDY; MEASUREMENT; MOLECULAR PROBE; OFF PUMP CORONARY SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SURGICAL PATIENT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CORONARY ARTERY BYPASS, OFF-PUMP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE PERIOD;

EID: 33745022351     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.01.058     Document Type: Article

References (25)

1. Cremer J., Martin M., Redl H., Bahrami S., Abraham C., Graeter T., Haverich A., Schlag G., and Borst H.G. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61 (1996) 1714-1720
2. Cleveland Jr. J.C., Shroyer A.L., Chen A.Y., Peterson E., and Grover F.L. Off-pump coronary artery bypass grafting decreases risk-adjusted mortality and morbidity. Ann Thorac Surg 72 (2001) 1282-1288 discussion 1288-9
3. Matata B.M., Sosnowski A.W., and Galinanes M. Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. Ann Thorac Surg 69 (2000) 785-791
4. Czerny M., Baumer H., Kilo J., Lassnigg A., Hamwi A., Vukovich T., Wolner E., and Grimm M. Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. Eur J Cardiothorac Surg 17 (2000) 737-742
5. Moat N.E., Rebuck N., Shore D.F., Evans T.W., and Finn A.H. Humoral and cellular activation in a simulated extracorporeal circuit. Ann Thorac Surg 56 (1993) 1509-1514
6. Struber M., Cremer J.T., Gohrbandt B., Hagl C., Jankowski M., Volker B., Ruckoldt H., Martin M., and Haverich A. Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass. Ann Thorac Surg 68 (1999) 1330-1335
7. Calandra T., and Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3 (2003) 791-800
8. Baugh J.A., and Bucala R. Macrophage migration inhibitory factor. Crit Care Med 30 (2002) S27-S35
9. Gando S., Nishihira J., Kobayashi S., Morimoto Y., Nanzaki S., and Kemmotsu O. Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome. Intensive Care Med 27 (2001) 1187-1193
10. Lehmann L.E., Novender U., Schroeder S., Pietsch T., von Spiegel T., Putensen C., Hoeft A., and Stuber F. Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis. Intensive Care Med 27 (2001) 1412-1415
11. Gando S., Nishihira J., Kemmotsu O., Kobayashi S., Morimoto Y., Matsui Y., and Yasuda K. An increase in macrophage migration inhibitory factor release in patients with cardiopulmonary bypass surgery. Surg Today 30 (2000) 689-694
12. Takahashi M., Nishihira J., Shimpo M., Mizue Y., Ueno S., Mano H., Kobayashi E., Ikeda U., and Shimada K. Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes. Cardiovasc Res 52 (2001) 438-445
13. Fukuzawa J., Nishihira J., Hasebe N., Haneda T., Osaki J., Saito T., Nomura T., Fujino T., Wakamiya N., and Kikuchi K. Contribution of macrophage migration inhibitory factor to extracellular signal-regulated kinase activation by oxidative stress in cardiomyocytes. J Biol Chem 277 (2002) 24889-24895
14. Garner L.B., Willis M.S., Carlson D.L., DiMaio J.M., White M.D., White D.J., Adams IV G.A., Horton J.W., and Giroir B.P. Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor. Am J Physiol Heart Circ Physiol 285 (2003) H2500-H2509
15. Willis M.S., Carlson D.L., Dimaio J.M., White M.D., White D.J., Adams IV G.A., Horton J.W., and Giroir B.P. Macrophage migration inhibitory factor mediates late cardiac dysfunction after burn injury. Am J Physiol Heart Circ Physiol 288 (2005) H795-H804
16. Matsui Y., Okamoto H., Jia N., Akino M., Uede T., Kitabatake A., and Nishihira J. Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis. J Mol Cell Cardiol 37 (2004) 557-566
17. Donn R.P., Shelley E., Ollier W.E., and Thomson W. A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 44 (2001) 1782-1785
18. Donn R., Alourfi Z., De Benedetti F., Meazza C., Zeggini E., Lunt M., Stevens A., Shelley E., Lamb R., Ollier W.E., Thomson W., and Ray D. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 46 (2002) 2402-2409
19. Baugh J.A., Chitnis S., Donnelly S.C., Monteiro J., Lin X., Plant B.J., Wolfe F., Gregersen P.K., and Bucala R. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 3 (2002) 170-176
20. De Benedetti F., Meazza C., Vivarelli M., Rossi F., Pistorio A., Lamb R., Lunt M., Thomson W., Ravelli A., Donn R., and Martini A. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 48 (2003) 1398-1407
21. Le Gall J.R., Lemeshow S., and Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. J Am Med Assoc 270 (1993) 2957-2963
22. Ascione R., Lloyd C.T., Underwood M.J., Lotto A.A., Pitsis A.A., and Angelini G.D. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 69 (2000) 1198-1204
23. Gu Y.J., Mariani M.A., van Oeveren W., Grandjean J.G., and Boonstra P.W. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting. Ann Thorac Surg 65 (1998) 420-424
24. Yu C.M., Lau C.P., Lai K.W., Huang X.R., Chen W.H., and Lan H.Y. Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction. Am J Cardiol 88 (2001) 774-777
25. Barton A., Lamb R., Symmons D., Silman A., Thomson W., Worthington J., and Donn R. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun 4 (2003) 487-491